本页面由Tiger Trade Technology Pte. Ltd.提供服务

Collegium Pharmaceutical, Inc.

21.53
-0.5200-2.36%
盘后:21.550.0200+0.09%19:30 EDT
成交量:84.64万
成交额:1,834.00万
市值:7.01亿
市盈率:16.95
高:22.21
开:22.05
低:21.46
收:22.05
52周最高:50.79
52周最低:21.43
股本:3,255.56万
流通股本:2,821.13万
量比:1.45
换手率:3.00%
股息:- -
股息率:- -
每股收益(TTM):1.27
每股收益(LYR):1.73
净资产收益率:17.61%
总资产收益率:5.75%
市净率:2.25
市盈率(LYR):12.45

数据加载中...

2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities